|
 |
 |
 |
 |
 |
 |
 |
 |
news
|
At Pulmatrix, we are committed to communicating clear and consistent information. Here we feature current and historic content concerning our science, our pipeline, and our corporate initiatives and achievements. Please check in often for the most recent press releases and information. Pulmatrix Closes $30.2 Million in Series B Financing 11/02/09 Pulmatrix Receives $2.2 Million from NIH/NIAID to Develop Novel Inhaled Influenza Therapeutics 05/01/09 Pulmatrix Announces Ph 1b/2a Clinical Trial of Novel iCALM Therapy for Flu |
|
© 2011 Pulmatrix, Inc. All Rights Reserved
home about pulmatrix science pipeline applications publications news careers contact site design
home about pulmatrix science pipeline applications publications news careers contact site design